Martin Kleckner, III PHD MBA concentrates on business development, commercialization, capitalization and mentoring of life science start-up ventures including 501(3)c not-for-profit initiatives.
background comprises 26 years guiding emerging and Fortune 100 companies with new technology commercialization throughout Europe, Asia & the Americas.
work comprises a heavy emphasis on business & market development for healthcare companies and hospital systems.
guides corporations worldwide on the formation of effective business alliances with hospital systems and GPOs.
specializes in healthcare economics, quality of care, clinical outcomes, operations design & development, sales and market development, cost & productivity and business alliance management initiatives.
Experience includes six-sigma process facilitation; medical technology cost effectiveness & economic impact studies, work flows analyses, process mapping, sales and market development tools, and operations management models.
He is currently serving as Chief Operations Officer for The Nicholas Conor Institute for Pediatric Cancer Research, Inc.
, specializing in the translation of new molecular biology (genomics and proteomics) diagnostics and treatments.